Ocular Therapeutix
OCUL
OCUL
122 hedge funds and large institutions have $176M invested in Ocular Therapeutix in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $215M → $176M (-$39.2M)
24% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 21
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
122
Holding in Top 10
2
Calls
$446K
Puts
$180K
Top Buyers
| 1 | +$4.09M | |
| 2 | +$2.29M | |
| 3 | +$2.23M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$2.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.24M |
Top Sellers
| 1 | -$2.39M | |
| 2 | -$1.55M | |
| 3 | -$1.19M | |
| 4 |
Two Sigma Advisers
New York
|
-$1.19M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.18M |